NATCO PHARMA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,028 INR | +0.66% |
|
+2.85% | +26.69% |
| 04-09 | Natco Pharma Gets US FDA Warning Letter after Inspection of Kothur, India Unit | MT |
| 03-27 | NATCO Pharma Limited Announces Board Appointments | CI |
Chart calendar NATCO Pharma Limited
e986d06f2d6d67.LVllh13620gp-XxT7Xu0GYdVtncG_77XkJjymCkShVg.WzIG0xK5tRtTqA8foDXfcbcHzBA_nobj6Pqq2kJ8syB5IFLVLZWuHG-9KQ~1863b318d7a83d663abfbe48a0e67b4b
Upcoming events on NATCO Pharma Limited
Past events on NATCO Pharma Limited
| 22/04/2024 07:30 | Investor Meeting - HSBC Global |
| 06/03/2024 06:30 | Investor Meeting - ICICI Securities |
| 28/02/2024 03:30 | Investec Promoter & Founder Conference |
| 15/02/2024 05:30 | Q3 2024 Earnings Call |
| 14/02/2024 08:38 | Q3 2024 Earnings Release |
| 15/12/2023 06:00 | Investor Meeting - Kotak PCG |
| 29/11/2023 03:30 | Investor Meeting |
| 28/11/2023 03:30 | Investor Meeting - Day 1 |
| 15/11/2023 05:30 | Q2 2024 Earnings Call |
| 14/11/2023 08:44 | Q2 2024 Earnings Release |
| 29/09/2023 06:00 | Annual General Meeting |
| 10/08/2023 06:30 | Q1 2024 Earnings Call |
| 09/08/2023 10:20 | Q1 2024 Earnings Release |
| 30/05/2023 06:30 | Q4 2023 Earnings Call |
| 29/05/2023 09:52 | Q4 2023 Earnings Release |
| 10/02/2023 05:30 | Q3 2023 Earnings Call |
| 09/02/2023 08:27 | Q3 2023 Earnings Release |
| 11/11/2022 05:30 | Interim 2023 Earnings Call |
| 10/11/2022 08:11 | Interim 2023 Earnings Release |
| 30/09/2022 06:00 | Annual General Meeting |
Past dividends on NATCO Pharma Limited
| 25/02/2024 | Interim Payment 1.25 INR |
| 23/11/2023 | Interim Payment 1.25 INR |
| 21/08/2023 | Interim Payment 7 INR |
| 20/02/2023 | Interim Payment 1.25 INR |
| 20/11/2022 | Interim Payment 0.75 INR |
| 18/08/2022 | Interim Payment 3.5 INR |
| 23/02/2022 | Interim Payment 2 INR |
| 22/11/2021 | Interim Payment 0.5 INR |
| 23/08/2021 | Interim Payment 2 INR |
| 21/02/2021 | Interim Payment 1 INR |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 20 945 22 060 -5.05% | 19 150 19 446 -1.52% | 20 521 21 294 -3.63% | 19 448 19 848 -2.02% | 27 071 26 844 0.85% | 39 185 |
|
EBITDA Million INR | Released Forecast Spread | 7 948 9 009 -11.77% | 5 826 6 531 -10.79% | 6 062 6 289 -3.61% | 2 635 5 360 -50.84% | 9 356 9 761 -4.15% | 16 899 |
|
EBIT Million INR | Released Forecast Spread | 7 138 8 815 -19.03% | 4 828 5 211 -7.35% | 4 893 5 247 -6.75% | 1 209 4 105 -70.55% | 7 718 8 088 -4.57% | 15 221 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 8 247 8 947 -7.83% | 5 687 6 043 -5.88% | 5 796 6 107 -5.09% | 2 022 5 124 -60.54% | 8 619 9 068 -4.96% | 16 001 |
|
Net income Million INR | Released Forecast Spread | 6 444 6 969 -7.54% | 4 608 4 832 -4.64% | 4 409 4 739 -6.95% | 1 700 3 978 -57.26% | 7 153 7 188 -0.49% | 13 212 |
|
EPS INR | Released Forecast Spread | 34,9 37,8 -7.75% | 25,3 28,1 -10.08% | 24,2 26,0 -7.15% | 9,32 21,9 -57.44% | 39,2 39,5 -0.77% | 73,2 |
| Announcement Date | 27/05/19 | 17/06/20 | 17/06/21 | 30/05/22 | 29/05/23 | - |
Quarterly results
| Fiscal Period | March | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 3 313 4 556 -27.29% | 4 103 4 479 -8.4% | 3 772 4 390 -14.08% | 5 605 4 620 21.31% | 5 968 5 662 5.4% | 8 846 8 159 8.42% | 4 321 6 309 -31.51% | 4 925 5 421 -9.14% | 8 979 8 321 7.91% | 11 405 11 402 0.02% | 10 790 | 5 742 | 9 922 |
|
EBITDA Million INR | Released Forecast Spread | 762 1 268 -39.91% | 1 098 1 179 -6.84% | 705 1 134 -37.82% | 1 018 1 145 -11.05% | -186 2 002 -109.29% | 3 953 3 662 7.93% | 953 2 034 -53.14% | 1 059 1 322 -19.91% | 3 391 3 606 -5.95% | 5 280 5 247 0.63% | 4 930 | 1 284 | 4 376 |
|
EBIT Million INR | Released Forecast Spread | 692 | 3 504 | |||||||||||
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 910 853 6.68% | 698 1 067 -34.58% | 910 1 144 -20.45% | -496 1 323 -137.49% | 3 858 2 889 33.54% | 814 833 -2.28% | 3 244 1 583 104.93% | 5 000 4 273 17.01% | 4 672 | 4 732 | |||
|
Net income Million INR | Released Forecast Spread | 530 1 027 -48.39% | 750 779 -3.69% | 651 775 -15.96% | 804 862 -6.69% | -505 1 368 -136.92% | 3 204 2 192 46.17% | 568 1 385 -59% | 623 942 -33.87% | 2 758 2 596 6.22% | 4 203 3 957 6.22% | 5 355 | 833 | 3 241 |
|
EPS INR | Released Forecast Spread | 4,11 4,35 -5.52% | 3,57 4,80 -25.63% | 4,40 4,60 -4.35% | -2,77 7,30 -137.95% | 17,6 12,4 41.53% | 3,11 5,10 -39.02% | 3,41 3,90 -12.56% | 15,1 6,80 122.21% | 23,3 19,0 22.42% | 21,4 | 3,68 | 15,0 | |
| Announcement Date | 17/06/21 | 12/08/21 | 11/11/21 | 14/02/22 | 30/05/22 | 09/08/22 | 10/11/22 | 09/02/23 | 29/05/23 | 09/08/23 | - | - | - |
More events
Past sector events for NATCO Pharma Limited
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NATCOPHARM Stock
- Calendar NATCO Pharma Limited
